369 related articles for article (PubMed ID: 23598816)
1. The role of polymorphonuclear leukocyte trafficking in the perpetuation of inflammation during inflammatory bowel disease.
Brazil JC; Louis NA; Parkos CA
Inflamm Bowel Dis; 2013 Jun; 19(7):1556-65. PubMed ID: 23598816
[TBL] [Abstract][Full Text] [Related]
2. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
3. Potential roles of neutrophils in regulating intestinal mucosal inflammation of inflammatory bowel disease.
Zhou GX; Liu ZJ
J Dig Dis; 2017 Sep; 18(9):495-503. PubMed ID: 28857501
[TBL] [Abstract][Full Text] [Related]
4. Biologic therapy for inflammatory bowel disease.
Ardizzone S; Bianchi Porro G
Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil transepithelial migration and epithelial barrier function in IBD: potential targets for inhibiting neutrophil trafficking.
Chin AC; Parkos CA
Ann N Y Acad Sci; 2006 Aug; 1072():276-87. PubMed ID: 17057207
[TBL] [Abstract][Full Text] [Related]
6. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
Sartor RB
Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.
Kucharzik T; Walsh SV; Chen J; Parkos CA; Nusrat A
Am J Pathol; 2001 Dec; 159(6):2001-9. PubMed ID: 11733350
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
9. Colonic Epithelial Surfactant Protein D Expression Correlates with Inflammation in Clinical Colonic Inflammatory Bowel Disease.
Nexoe AB; Pilecki B; Von Huth S; Husby S; Pedersen AA; Detlefsen S; Marcussen N; Moeller JB; Holmskov U; Sorensen GL
Inflamm Bowel Dis; 2019 Jul; 25(8):1349-1356. PubMed ID: 30753482
[TBL] [Abstract][Full Text] [Related]
10. Chemokine and cytokine levels in inflammatory bowel disease patients.
Singh UP; Singh NP; Murphy EA; Price RL; Fayad R; Nagarkatti M; Nagarkatti PS
Cytokine; 2016 Jan; 77():44-9. PubMed ID: 26520877
[TBL] [Abstract][Full Text] [Related]
11. Contribution of Blood Vessel Activation, Remodeling and Barrier Function to Inflammatory Bowel Diseases.
Britzen-Laurent N; Weidinger C; Stürzl M
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982601
[TBL] [Abstract][Full Text] [Related]
12. Intestinal barrier dysfunction in inflammatory bowel diseases.
McGuckin MA; Eri R; Simms LA; Florin TH; Radford-Smith G
Inflamm Bowel Dis; 2009 Jan; 15(1):100-13. PubMed ID: 18623167
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil-mediated activation of epithelial protease-activated receptors-1 and -2 regulates barrier function and transepithelial migration.
Chin AC; Lee WY; Nusrat A; Vergnolle N; Parkos CA
J Immunol; 2008 Oct; 181(8):5702-10. PubMed ID: 18832729
[TBL] [Abstract][Full Text] [Related]
14. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil extracellular traps in inflammatory bowel diseases: Implications in pathogenesis and therapeutic targets.
Dos Santos Ramos A; Viana GCS; de Macedo Brigido M; Almeida JF
Pharmacol Res; 2021 Sep; 171():105779. PubMed ID: 34298111
[TBL] [Abstract][Full Text] [Related]
16. Blockade of PLD2 Ameliorates Intestinal Mucosal Inflammation of Inflammatory Bowel Disease.
Zhou G; Yu L; Yang W; Wu W; Fang L; Liu Z
Mediators Inflamm; 2016; 2016():2543070. PubMed ID: 27721573
[No Abstract] [Full Text] [Related]
17. Inflammatory bowel disease: beyond the boundaries of the bowel.
Actis GC; Rosina F; Mackay IR
Expert Rev Gastroenterol Hepatol; 2011 Jun; 5(3):401-10. PubMed ID: 21651357
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of IBD associated diarrhea.
Anbazhagan AN; Priyamvada S; Alrefai WA; Dudeja PK
Tissue Barriers; 2018; 6(2):e1463897. PubMed ID: 29737913
[TBL] [Abstract][Full Text] [Related]
19. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics.
Linskens RK; Huijsdens XW; Savelkoul PH; Vandenbroucke-Grauls CM; Meuwissen SG
Scand J Gastroenterol Suppl; 2001; (234):29-40. PubMed ID: 11768558
[TBL] [Abstract][Full Text] [Related]
20. FOXO3 Deficiency in Neutrophils Drives Colonic Inflammation and Tumorigenesis.
Ghimire J; Iftikhar R; Penrose HM; Snarski P; Ruiz E; Savkovic SD
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
